pipeline
A robust pipeline in pursuit of transformative therapies
Autologous CD19 CAR-T cell therapy Qartemi® is used in treatment of relapsed and refractory Non Hodgkin’s Lymphoma (NHL). Varnimcabtagene autoleucel, arising out of our collaboration with Hospital Clinic Barcelona, is approved in Spain and India.
Products in Development
